Systems and methods for monitoring and controlling ultrasound power output and stability

Information

  • Patent Grant
  • 9011337
  • Patent Number
    9,011,337
  • Date Filed
    Wednesday, July 11, 2012
    11 years ago
  • Date Issued
    Tuesday, April 21, 2015
    9 years ago
Abstract
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.
Description
BACKGROUND

Temperatures change in a treatment device under operate can affect the stability of the device. Cooling the device may help stability, however, cooling device are bulky and require additional energy to operate. Accordingly, new approaches to monitoring ultrasound energy that is transmitted into a region of interest are needed.


SUMMARY

Various embodiments described herein provide methods and systems for monitoring ultrasound energy. Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon a change in the power level. In some embodiments, the method can comprise changing power provided to a transducer providing the ultrasound energy based on the adjusting the frequency of the ultrasound energy. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon a change in the temperature; and maintaining the power level threshold of the ultrasound energy.





DRAWINGS

The present disclosure will become more fully understood from the description and the accompanying drawings, wherein:



FIG. 1 is a cross sectional view illustrating tissue layers and ultrasound energy directed to a portion of the tissue layers, in accordance with various non-limiting embodiments;



FIG. 2 is a graph illustrating ultrasound efficiency at a frequency, in accordance with various non-limiting embodiments;



FIG. 3 is a graph illustrating ultrasound efficiency a frequency, in accordance with various nonlimiting embodiments;



FIG. 4 is a block diagram illustrating a system in accordance with various non-limiting embodiments;



FIG. 5 is a block diagram illustrating a system in accordance with various non-limiting embodiments;



FIG. 6 is a block diagram illustrating a system in accordance with various non-limiting embodiments.



FIG. 7 is a block diagram illustrating a system in accordance with various non-limiting embodiments; and



FIG. 8 is a block diagram illustrating a system in accordance with various non-limiting embodiments.





DESCRIPTION

The following description is merely exemplary in nature and is in no way intended to limit the various embodiments, their application, or uses. As used herein, the phrase “at least one of A, B, and C” should be construed to mean a logical (A or B or C), using a non-exclusive logical “or.” As used herein, the phrase “A, B and/or C” should be construed to mean (A, B, and C) or alternatively (A or B or C), using a non-exclusive logical “or.” It should be understood that steps within a method may be executed in different order without altering the principles of the present disclosure.


The drawings described herein are for illustrative purposes only of selected non-limiting embodiments and not all possible implementations, and are not intended to limit the scope of any of the various embodiments disclosed herein or any equivalents thereof. It is understood that the drawings are not drawn to scale. For purposes of clarity, the same reference numbers will be used in the drawings to identify similar elements.


The various embodiments may be described herein in terms of various functional components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions. For example, various embodiments may employ various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the embodiments may be practiced in any number of medical contexts and that the various embodiments relating to a method and system for acoustic energy deposition in tissue, as described herein, are merely indicative of one of the many applications for the invention. For example, the principles, features and methods discussed may be applied to any medical application. Further, various aspects of the various embodiments may be suitably applied to cosmetic applications. Moreover, some of the embodiments may be applied to cosmetic enhancement of skin and/or various soft tissue layers.


Various embodiments provide methods and systems to adjust a temperature of a transducer, in order to maintain maximum efficiency of power applied by the transducer. Some embodiments provide methods and systems to minimize or eliminate temperature saturation of a transducer during the delivery of power to the transducer. In some embodiments, methods and systems can control a temperature of a transducer to maintain a desired frequency of energy transmission at a maximum power.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring, a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon a change in the power level. In some embodiments, the method can comprise changing power provided to a transducer providing the ultrasound energy based on the adjusting the frequency of the ultrasound energy. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon a change in the temperature; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature is above the temperature threshold.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of temperature. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold. In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when a temperature of the ultrasound transducer is above the temperature threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon a change in the voltage; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can thither comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time; communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon an change in the voltage; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon an change in the temperature; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting, the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time; communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon an change in the voltage; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon an change in the temperature; and maintaining the power level threshold of the ultrasound energy.


In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.


In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.


In some embodiments, temperature can be monitored by monitoring changes in time of flight of the ultrasound energy from the transducer. In some embodiments, temperature can be monitored by a piezoelectric sensor that may be a portion of transducer, as described herein. In various embodiments, a controller may use a look up table to change a parameter. In some embodiments, controller can employ hardware, software, or a combination of both to change a parameter such as power, voltage or current.


With reference to FIG. 1, a cross sectional view of tissue layers and ultrasound energy directed to at least one of the tissue layers, according to various embodiments of the present invention, is illustrated. The tissue layers illustrated are skin surface 204, epidermal layer 202, dermis layer 206, fat layer 208, SMAS layer 210, and muscle and connective tissue layer 212. Ultrasound probe 205 transmits ultrasound energy 220 transmitting in ROI 215. In various embodiments, ultrasound probe 205 is capable of transmitting ultrasound energy 220 transmitting at variable depths in ROI 215, such as, for example, the depths described herein. Ultrasound probe 205 is capable of transmitting therapeutic ultrasound energy as a single frequency, variable frequencies, or a plurality of frequencies, such as, for example, within the frequency ranges described herein. Ultrasound probe 205 is capable of transmitting ultrasound energy 220 transmitting for variable time periods or to pulse the transmission over time, such as, for example, those time intervals described herein. Ultrasound probe 205 is capable of providing various energy levels of therapeutic ultrasound energy, such as, for example, the energy levels described herein.


Ultrasound probe 205 may be individual hand-held device, or may be part of a treatment system or part of cosmetic enhancement system. The ultrasound probe 205 can provide both therapeutic ultrasound energy and imaging ultrasound energy. However, ultrasound probe 205 may provide only therapeutic ultrasound energy. Ultrasound probe 205 may comprise a therapeutic transducer and a separate imaging transducer. Ultrasound probe 205 may comprise a transducer or a transducer array capable of both therapeutic and imaging applications. According an alternative embodiment, ultrasound probe 205 is coupled directly to one of the tissue layers, as opposed to skin surface 204 to treat the tissue layer. For example, ultrasound probe 205 can be integrated to or attached to a tool, such as, for example, an arthroscopic tool, laparoscopic tool, or an endoscopic tool that may be inserted into a patient's body with minimal invasiveness.


In various embodiments, the ultrasound energy level is in a range of about 0.1 joules to about 500 joules in order to create an ablative lesion. However, the ultrasound energy 108 level can be in a range of from about 0.1 joules to about 100 joules, or from about 1 joules to about 50 joules, or from about 0.1 joules to about 10 joules, or from about 50 joules to about 100 joules, or from about 100 joules to about 500 joules, or from about 50 joules to about 250 joules.


Further, the amount of time ultrasound energy is applied at these levels varies in the range from approximately 1 millisecond to several minutes. However, a range can be from about 1 millisecond to about 5 minutes, or from about 1 millisecond to about 1 minute, or from about 1 millisecond to about 30 seconds, or from about 1 millisecond to about 10 seconds, or from about 1 millisecond to about 1 second, or from about millisecond to about 0.1 seconds, or about 0.1 seconds to about 10 seconds, or about 0.1 seconds to about 1 second, or from about 1 millisecond to about 200 milliseconds, or from about 1 millisecond to about 0.5 seconds.


The frequency of the ultrasound energy can be in a range from about 0.1 MHz to about 100 MHz, or from about 0.1 MHz to about 50 MHz, or from about 1 MHz to about 50 MHz or about 0.1 MHz to about 30 MHz, or from about 10 MHz to about 30 MHz, or from about 0.1 MHz to about 20 MHz, or from about 1 MHz to about 20 MHz, or from about 20 MHz to about 30 MHz.


The frequency of the ultrasound energy can be in a range from about 1 MHz to about 12 MHz, or from about 5 MHz to about 15 MHz, or from about 2 MHz to about 12 MHz or from about 3 MHz to about 7 MHz.


In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 0 mm to about 150 mm, or from about 0 mm to about 100 mm, or from about 0 mm to about 50 mm, or from about 0 mm to about 30 mm, or from about 0 mm to about 20 mm, or from about 0 mm to about 10 mm, or from about 0 mm to about 5 mm. In some embodiments, the ultrasound energy can be transmitted to depths below a skin surface in a range from about 5 mm to about 150 mm, or from about 5 mm to about 100 mm, or from about 5 mm to about 50 mm, or from about 5 mm to about 30 mm, or from about 5 mm to about 20 mm, or from about 5 mm to about 10 mm. In some embodiments, the ultrasound energy can be transmitted to depths below a skin surface in a range from about 10 mm to about 150 mm, or from about 10 mm to about 100 mm, or from about 10 mm to about 50 mm, or from about 10 mm about 30 mm, or from about 10 mm to about 20 mm, or from about 0 mm to about 10 mm.


In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in the range from about 20 mm to about 150 mm, or from about 20 mm to about 100 mm, or from about 20 mm to about 50 mm, or from about 20 mm to about 30 mm. In some embodiments, the ultrasound energy can be transmitted to depths at below a skin surface in a range from about 30 mm to about 150 mm, or from about 30 mm to about 100 mm, or from about 30 mm to about 50 mm. In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 50 mm to about 150 mm, or from about 50 mm to about 100 mm. In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 20 mm to about 60 mm, or from about 40 mm to about 80 mm, or from about 10 mm to about 40 mm, or from about 5 mm to about 40 mm, or from about 0 mm to about 40 mm, or from about 10 mm to about 30 mm, or from about 5 mm to about 30 mm, or from about 0 mm to about 30 mm.


In various embodiments, a temperature of tissue receiving the ultrasound energy can be in a range from 30° C. to about 100° C., or from 43° C. to about 60° C., or from 50° C. to about 70° C., or from 30° C.; to about 50° C., or from 43° C. to about 100° C., or from 33° C. to about 100° C., or from 30° C. to about 65° C., or from 33° C. to about 70° C., as well as variations thereof.


Also, depending at least in part upon a specific biological effect and the tissue layers that are targeted, temperature of tissue receiving the ultrasound energy within ROI 215 may change in a range from approximately 10° C. to about 15° C. in various embodiments, a temperature of tissue receiving the ultrasound energy is raised to a temperature in a range from about 40° C. to about 55° C., or from about 43° C. to about 48° C., or below a threshold of ablation of the tissue.


Moving to FIG. 2, a graph illustrates efficiency of an ultrasound transducer at specific frequency fc, in accordance with various embodiments. Efficiency of a transducer is defined as the ratio of the power output in the desired form to the total power input. Mathematically, if Pin represents the total power input and Pout represents the power output in the desired form, then the efficiency E, as a ratio between 0 and 1, is given by:

E=Pout/Pin  Equation 1


If E % represents the efficiency as a percentage, then:

E %=100Pout/Pin  Equation 2


In general, a transducer is not 100% efficient and power is typically lost during the operation of the transducer in the form of heat. However, for a high-Q transducer, efficiency can approach 100% and heat generated by the transducer is minimized. A transducer is most efficient at specific frequency fc, as illustrated in FIG. 2. The transducer has the maximum power output at frequency fc.


When a transducer operates, the transducer heats up over time and the temperature of the transducer changes. As the temperature of the transducer changes, the resonant frequency will shift towards frequency ft, as illustrated in FIG. 3. This frequency shift decreases the efficiency of the transducer and, the power output from the transducer is significantly lower in the example of FIG. 3 as compared to the example of FIG. 2.


Transducer efficiency decreases due to changes in temperature of the transducer as a function of time. In addition, a change in temperature of the transducer will cause a frequency shift. The frequency shift changes as a function of increasing temperature of the transducer. A frequency shift decreases efficiency and can cause a system to change total power input to make up for a loss of power applied by the transducer. A frequency shift will change the impedance of the transducer.


In various embodiments, systems and methods, described herein, monitor transducer temperature and report changes in temperature to a controller to modify the frequency generation to the transducer. In various embodiments, systems and methods can monitor transducer temperature and report changes in temperature to a controller to modify the total power input to the transducer. In various embodiments, systems and methods can monitor efficiency and controls transducer temperature to prevent energy transmission from a shift in frequency.


In various embodiments, systems and methods can at least one of monitor transducer temperature and control transducer temperature. In various embodiments, systems and methods can operate the transducer to at or near maximum efficiency of power over a period of time. In various embodiments, systems and methods can operate the transducer to at or near maximum efficiency of power as a temperature of the transducer changes. In various embodiments, systems and methods can modify temperature of the transducer to maintain operation at or near maximum efficiency of power. In various embodiments, systems and methods can prevent a change in impedance of the transducer.


In some embodiments, energy emission, such as, an ultrasound emission, can be directed to targeted tissue to initiate a desired treatment to the targeted tissue. If the power of the energy emission, such as, an ultrasound emission, is too high, the targeted tissue can be permanently damaged, which provide pain to the patient being treated. In addition, if the power of the energy emission such as, an ultrasound emission, is too high, the desired treatment to the targeted tissue may not be effective. If the power of the energy emission, such as, an ultrasound emission, is too low, the desired treatment to the targeted tissue may not be effective.


If the efficiency of the transducer degrades, the power of energy emission decreases. If the temperature of the transducer changes, the efficiency of the transducer changes and the power of energy emission decreases. For the most effective treatment to targeted tissue, power of energy emission is constant. Various embodiments provide methods and systems to provide constant energy emission from transducer 110 that is directed to targeted tissue.


Referring to FIG. 4, system 131 is illustrated, in accordance with some embodiments. System 131 can comprise drivers 102, power sensor 104, transducer 110, controller 115, and oscillator 120. In various embodiments, oscillator 120 generates a frequency which is communicated to drivers 102 to power transducer 110 to produce energy transmission 150 at the frequency. Oscillator 120 can be an oscillator or any frequency generator, now known or later developed. For example, oscillator 120 can be but is not limited to, a function generator, a frequency generator, a waveform generator, a signal generator, pitch generator, a wave generator, or a pulse generator, frequency synthesizer, direct digital synthesizer, or combinations thereof. In some embodiments, oscillator 120 can be combined with or integrated to drivers 102. In some embodiments, oscillator 120 is programmable. In some embodiments, controller 115 can be combined with or integrated to at least one of oscillator 120 and drivers 102. In some embodiments, power sensor 104 can be combined with or integrated to at least one of oscillator 120, controller 115 and drivers 102. In some embodiments, power sensor 104 can be combined with or integrated to at least one of oscillator 120, and drivers 102. In some embodiments, power sensor 104 can be combined with or integrated to at least one of controller 115 and drivers 102. In some embodiments, power sensor 104 can be combined with or integrated to at least one of oscillator 120, and controller 115. In some embodiments, power sensor 104 can be combined with or integrated to drivers 102. In some embodiments, power sensor 104 can be combined with or integrated to oscillator 120. In some embodiments, power sensor 104 can be combined with or integrated to controller 115.


In some embodiments, power sensor 104 monitors power input from drivers 102 to transducer 110. In some embodiments, power sensor 104 communicates with controller 115, which controls oscillator 120. In some embodiments, controller 115 receives signal from power sensor 104 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, power sensor 104 communicates a power level of the power input from drivers 102.


As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, drivers 102 changes the power input to transducer 110. In some embodiments, power sensor 104 detects the change in power input to transducer 110 and communicates with controller 115, which controls oscillator 120 to change in the power level of the power input from supply and/or drivers 102. In some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from the power sensor 104. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102. In some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the power input from the drivers 102 to transducer 110 below a threshold, power sensor 104 communicates this elevated power level to controller 115, which controls oscillator 120 for another generation of a correction to the frequency. In some embodiments, system 131 comprises a shut off power function, which is initiated if power sensor 104 detects a power level that is above a predetermined threshold, in some embodiments, the shut off power function prevents the damaging or destroying of transducer 110.


In some embodiments, the thickness of the transduction element of transducer 110 may be configured to be uniform. That is, the transduction element may be configured to have a thickness that is generally substantially the same throughout. In another exemplary embodiment, the transduction element may also be configured with a variable thickness, and/or as a multiple damped device. For example, the transduction element of transducer 110 may be configured to have a first thickness selected to provide a specific operating frequency of a lower range, for example from approximately 1 kHz to 3 MHz. The transduction element may also be configured with a second thickness selected to provide a specific operating frequency of a higher range, for example from approximately 3 to 100 MHz or other frequency ranges described herein.


In yet another exemplary embodiment, transducer 110 may be configured as a single broadband transducer excited with two or more frequencies to provide an adequate output for raising the temperature within ROI 215 to the desired level. Transducer 110 may also be configured as two or more individual transducers, wherein each transducer 110 may comprise a transduction element. The thickness of the transduction elements may be configured to provide specific-operating frequencies in a desired treatment range. For example, in some embodiments, transducer 110 may comprise a first transducer 110 configured with a first transduction element having a thickness corresponding to a specific frequency range of approximately 1 MHz to 3 MHz, and a second transducer 110 configured with a second transduction element having a thickness corresponding to a specific frequency of approximately 3 MHz to 100 MHz or frequency ranges described herein.


Moreover, in some embodiments, any variety of mechanical lenses or variable focus lenses, e.g. liquid-filled lenses, may also be used to focus and or defocus the energy field. For example, transducer 110 may also be configured with an electronic focusing array in combination with one or more transduction elements to facilitate changed flexibility in treating ROI 215. Array may be configured in a manner similar to transducer 110. That is, array may be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays. Accordingly, the electronic apertures of array may be manipulated, driven, used, configured to produce and/or deliver energy in a manner corresponding to the phase variation caused by the electronic time delay. For example, these phase variations may be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in ROI 215.


Transduction elements may be configured to be concave, convex, and/or planar. For example, transduction elements can be configured to be concave in order to provide focused energy for treatment of ROI 215. In another exemplary embodiment, transduction elements may be configured to be substantially flat in order to provide substantially uniform energy to ROI 215. In addition, transduction elements may be configured to be any combination of concave, convex, and/or substantially flat structures. For example, a first transduction element may be configured to be concave, while a second transduction element may be configured to be substantially flat.


Moreover, transduction element can be any distance from the skin surface 204. In that regard, it can be far away from the skin surface 204 disposed within a long transducer 110 or it can be just a few millimeters from skin surface 204. In certain exemplary embodiments, positioning the transduction element closer to skin surface 204 is better for transmitting ultrasound at high frequencies. Moreover, both two and three dimensional arrays of transduction elements can be used in various embodiments.


In some embodiments, transducer 110 may also be configured as an annular array to provide planar, focused and/or defocused acoustical energy. For example, in some embodiments, an annular array may comprise a plurality of rings. Rings may be mechanically and electrically isolated into a set of individual elements, and may create planar, focused, or defocused waves. For example, such waves can be specified on-axis, such as by methods of adjusting corresponding phase delays. An electronic focus may be moved along various depth positions in ROI 215, and may enable variable strength or beam tightness, while an electronic defocus may have varying amounts of defocusing. In some embodiments, a lens and/or convex or concave shaped annular array may also be provided to aid focusing or defocusing such that any time differential delays can be reduced. Movement of annular array in one, two or three-dimensions, or along any path, such as through use of probes, motion mechanisms, any conventional robotic arm mechanisms, and the like may be implemented to scan and/or treat a volume or any corresponding space within ROI 215.


In FIG. 5, system 132 is illustrated, in accordance with some embodiments. System 132 can comprise drivers 102, transducer 110, piezoelectric sensor 124, controller 115, and oscillator 120. In some embodiments, piezoelectric sensor 124 can be combined with or integrated to at least one of oscillator 120 and drivers 102. In some embodiments, piezoelectric; sensor 124 can be combined with or integrated into oscillator 1200 in some embodiments, piezoelectric sensor 124 can be combined with into integrated to drivers 102. In various embodiments, oscillator 120 generates a frequency which is communicated to drivers 102 to power transducer 110 to produce energy transmission 150 at the frequency. In some embodiments, piezoelectric sensor 124 monitors heat generated by transducer 110. In some embodiments, piezoelectric sensor 124 is coupled to transducer 110. In some embodiments, piezoelectric sensor 124 is integrated to transducer 110. For example, piezoelectric sensor 124 may be a portion of transducer 110, which that is isolated or insulation from the rest of transducer 110, and may comprise identical materials as transducer 110. However, in one aspect of this example, piezoelectric sensor 124 has the opposite temperature coefficient of transducer (same coefficient but opposite sign) and the piezoelectric sensor 124 changes temperature at the same rate as transducer 110, thus compensating for changes in temperature of transducer 110.


Piezoelectric sensor 124 can comprise ceramic, or any other material or combination of material described herein. In some embodiments, piezoelectric sensor 124 is configured with a temperature coefficient that is lower than the temperature coefficient of transducer 110. In some embodiments, piezoelectric sensor 124 is configured with temperature coefficient, which is negative. In various embodiments, piezoelectric sensor 124 generates an electric potential in response to a temperature change, and communicates this electric potential to controller 115, which controls oscillator 120. In some embodiments, piezoelectric sensor 124 communicates with oscillator 120. In some embodiments, controller 115 receives signal from piezoelectric sensor 124 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, piezoelectric sensor 124 communicates the heat generated by transducer 110, which can be communicated using temperature.


As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, heat generated by transducer 110 changes. For example, drivers 102 changes the power input to transducer 110, which can change the heat generated by transducer 110. In some embodiments, piezoelectric sensor 124 detects the change in heat generation by transducer 110 and communicates with controller 115, which controls oscillator 120, the change in heat generation, in some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from the piezoelectric device 124. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102, which can lower the amount of heat that is generated by transducer 110. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102. In some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the power input from the drivers 102 to transducer 110 below a threshold, piezoelectric sensor 124 communicates this elevated heat generation by transducer 110 to oscillator 124 for another generation of a correction to the frequency. In some embodiments, system 132 comprises a shut off power function, which is initiated if piezoelectric sensor 124 detects a heat generation level or a temperature of transducer 110 is above a predetermined threshold. In some embodiments, the shut off power function prevents the damaging or destroying of transducer 110.


Turning to FIG. 6, system 133 is illustrated, in accordance with some embodiments. System 133 can comprise drivers 102, transducer 110, temperature sensor 127, and oscillator 120. In some embodiments, temperature sensor 127 can be combined with or integrated to at least one of oscillator 120 and drivers 102. In various embodiments, oscillator 120 generates a frequency which is communicated to drivers 102 to power transducer 110 to produce energy transmission 150 at the frequency, in some embodiments, temperature sensor 127 monitors temperature of transducer 110. In some embodiments, temperature sensor 127 coupled to transducer 110, in some embodiments, temperature sensor 127 is integrated to transducer 110. Temperature sensor 127 can be any suitable temperature sensor, now known or later developed. In some embodiments, temperature sensor 127 communicates with controller 115, which communicates with oscillator 120. In some embodiments, temperature sensor 127 communicates with oscillator 120. In some embodiments, controller 115 receives signal from temperature sensor 127 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, temperature sensor 127 communicates the temperature of by transducer 110.


As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, heat generated by transducer 110 changes. For example, drivers 102 changes the power input to transducer 110, which can change the heat generated by transducer 110. In some embodiments, temperature sensor 127 detects the change in heat generation by transducer 110 and communicates with controller 115, which controls oscillator 120, the change in heat generation. In some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from the piezoelectric device 124. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102, which can lower the amount of heat that is generated by transducer 110. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102. In some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the power input from the drivers 102 to transducer 110 below a threshold, temperature sensor 127 communicates this elevated heat generation by transducer 110 to oscillator 124 for another generation of a correction to the frequency. In some embodiments, system 132 comprises a shut off power function, which is initiated if temperature sensor 127 detects a heat generation level or a temperature of transducer 110 is above a predetermined threshold. In some embodiments, the shut off power function prevents the damaging or destroying of transducer 110.


Moving to FIG. 7, system 135 is illustrated, in accordance with some embodiments. System 135 can comprise drivers 102, voltage monitor 105, transducer 110, controller 115, and oscillator 120. In various embodiments, oscillator 120 generates a frequency which is communicated to drivers 102 to power transducer 110 to produce energy transmission 150 at the frequency. Oscillator 120 can be an oscillator or any frequency generator, now known or later developed. For example, oscillator 120 can be but is not limited to, a function generator, a frequency generator, a waveform generator, a signal generator, pitch generator, a wave generator, or a pulse generator, frequency synthesizer, direct digital synthesizer, or combinations thereof. In some embodiments, oscillator 120 can be combined with or integrated to drivers 102. In some embodiments, oscillator 120 is programmable. In some embodiments, controller 115 can be combined with or integrated to at least one of oscillator 120 and drivers 102. In some embodiments, voltage monitor 105 can be combined with or integrated to at least one of oscillator 120, controller 115 and drivers 102. In some embodiments, voltage monitor 105 can be combined with or integrated to at least one of oscillator 120, and drivers 102. In some embodiments, voltage monitor 105 can be combined with or integrated to at least one of controller 115 and drivers 102. In some embodiments, voltage monitor 105 can be combined with or integrated to at least one of oscillator 120, and controller 115. In some embodiments, voltage monitor 105 can be combined with or integrated to drivers 102. In some embodiments, voltage monitor 105 can be combined with or integrated to oscillator 120. In some embodiments, voltage monitor 105 can be combined with or integrated to controller 115. In some embodiments, voltage monitor 105 monitors voltage of power from drivers 102 to transducer 110. In some embodiments, voltage monitor 105 communicates with controller 115, which controls oscillator 120. In some embodiments, controller 115 receives signal from voltage monitor 105 and controls a frequency generated by oscillator 120 based on the received signal, in some embodiments, voltage monitor 105 communicates a voltage level of the voltage of power from drivers 102.


As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, drivers 102 changes the voltage of power to transducer 110. In some embodiments, voltage monitor 105 detects the increase in voltage of power to transducer 110 and communicates with controller 115, which controls oscillator 120 to change in the voltage level of the voltage of power from supply and/or drivers 102. In some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from the voltage monitor 105. In some embodiments, the correction to the frequency lowers the voltage level of voltage of power from drivers 102. In some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the voltage of power from the drivers 102 to transducer 110 below a threshold, voltage monitor 105 communicates this elevated voltage level to controller 115, which controls oscillator 120 for another generation of a correction to the frequency. In some embodiments, system 135 comprises a shut off power function, which is initiated if voltage monitor 105 detects a voltage level that is above a predetermined threshold. In some embodiments, the shut off power function prevents the damaging or destroying of transducer 110.



FIG. 8 With reference to FIG. 8, system 135 is illustrated, in accordance with some embodiments. System 135 can comprise drivers 102, transducer 110, temperature sensor 127, and oscillator 120. In some embodiments, temperature sensor 127 can be combined with or integrated to at least one of oscillator 120 and drivers 102. In various embodiments, oscillator 120 generates a frequency which is communicated to drivers 102 to power transducer 110 to produce energy transmission 150 at the frequency. In some embodiments, temperature sensor 127 monitors temperature of transducer 110. In some embodiments, temperature sensor 127 coupled to transducer 110. In some embodiments, temperature sensor 127 is integrated to transducer 110. Temperature sensor 127 can be any suitable temperature sensor, now known or later developed. In some embodiments, temperature sensor 127 communicates with controller 115, which communicates with oscillator 120. In some embodiments, temperature sensor 127 communicates with oscillator 120. In some embodiments, controller 115 receives signal from temperature sensor 127 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, temperature sensor 127 communicates the temperature of by transducer 110. As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, drivers 102 changes the power to transducer 110, which change the voltage across the transducer 110. In some embodiments, controller 115 detects the change in voltage across transducer 110 and communicates with controller 115. In some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from controller 115. In some embodiments, the correction to the frequency lowers the voltage level of voltage across transducer 110, in some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the voltage across transducer 110 below a threshold, controller 115 communicates this elevated voltage level to oscillator 120 for another generation of a correction to the frequency.


As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in FIG. 3, heat generated by transducer 110 changes. For example, drivers 102 changes the power input to transducer 110 which can change the heat generated by transducer 110. In some embodiments, temperature sensor 127 detects the change in heat generation by transducer 110 and communicates with controller 115, which controls oscillator 120, the change in heat generation. In some embodiments, oscillator 120 generates a correction to the frequency which is communicated to the drivers 102, which is based on the communication from the piezoelectric device 124. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102, which can lower the amount of heat that is generated by transducer 110. In some embodiments, the correction to the frequency lowers the power level of power input from drivers 102. In some embodiments, energy transmission 150 is corrected to specific frequency fc as illustrated in FIG. 2. If this correction to specific frequency fc does not lower the power input from the drivers 102 to transducer 110 below a threshold, temperature sensor 127 communicates this elevated heat generation by transducer 110 to oscillator 124 for another generation of a correction to the frequency. In some embodiments, system 132 comprises a shut off power function, which is initiated if temperature sensor 127 detects a heat generation level or a temperature of transducer 110 is above a predetermined threshold. In some embodiments, the shut off power function prevents the damaging or destroying of transducer 110.


The following patents and patent applications are incorporated by reference: US Patent Application Publication No. 20050256406, entitled “Method and System for Controlled Scanning, Imaging, and/or Therapy” published Nov. 17, 2005; US Patent Application Publication No. 20060058664, entitled “System and Method for Variable Depth Ultrasound Treatment” published Mar. 16, 2006; US Patent Application Publication No. 20060084891, entitled “Method and System for Ultra-High Frequency Ultrasound Treatment” published Apr. 20, 2006; U.S. Pat. No. 7,530,958, entitled “Method and System for Combined Ultrasound Treatment” issued May 12, 2009; US Patent Application Publication No. 2008071255, entitled “Method and System for Treating Muscle, Tendon, Ligament, and Cartilage Tissue” published Mar. 20, 2008; U.S. Pat. No. 6,623,430, entitled “Method and Apparatus for Safely Delivering Medicants to a Region of Tissue Using Imaging, Therapy, and Temperature Monitoring Ultrasonic System,” issued Sep. 23, 2003; U.S. Pat. No. 7,571,336, entitled “Method and System for Enhancing Safety with Medical Peripheral Device by Monitoring if Host Computer is AC Powered” issued Aug. 4, 2009; US Patent Application Publication No. 20080281255, entitled “Methods and Systems for Modulating Medicants Using Acoustic Energy” published Nov. 13, 2008; US Patent Application Publication No. 20060116671, entitled “Method and System for Controlled Thermal Injury of Human Superficial Tissue,” published Jun. 1, 2006; US Patent Application Publication No. 20060111744, entitled “Method and System for Treatment of Sweat Glands,” published May 25, 2006; US Patent Application Publication No. 20080294073, entitled “Method and System for Non-Ablative Acne Treatment and Prevention,” published Oct. 8, 2009; U.S. Pat. No. 8,133,180, entitled “Method and System for Treating Cellulite,” issued Mar. 13, 2012; U.S. Pat. No. 8,066,641, entitled “Method and System for Photoaged Tissue,” issued Nov. 29, 2011; U.S. Pat. No. 7,491,171, entitled “Method and System for Treating. Acne and Sebaceous Glands,” issued Feb. 17, 2009; U.S. Pat. No. 7,615,016, entitled “Method and System for Treating Stretch Marks,” issued Nov. 10, 2009; and U.S. Pat. No. 7,530,356, entitled “Method and System for Noninvasive Mastopexy,” issued May 12, 2009.


It is believed that the disclosure set forth above encompasses at least one distinct invention with independent utility. While the invention has been disclosed herein, the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense as numerous variations are possible. The subject matter of the inventions includes all novel and non-obvious combinations and sub combinations of the various elements, features, functions and/or properties disclosed herein.


Various embodiments and the examples described herein are not intended to be limiting in describing the full scope of systems and methods of this invention. Equivalent changes, modifications and variations of various embodiments, materials, systems, and methods may be made within the scope of the present invention, with substantially similar results.

Claims
  • 1. A method of providing ultrasound energy having a stable power output, the method comprising: emitting ultrasound energy from an ultrasound transducer at a specific frequency and at a predetermined power level;monitoring a power level of the ultrasound energy over a time;communicating the power level to a controller;correcting a frequency of the ultrasound energy to the specific frequency upon the power level deviating for the predetermined, power level;monitoring a temperature of the ultrasound transducer over the time of the emitting ultrasound energy;communicating the temperature of the ultrasound transducer to the controller; andcorrecting the frequency of the ultrasound energy to the specific frequency upon a change in the temperature of the ultrasound transducer, wherein the change of temperature is outside a predetermined temperature range;thereby maximizing efficiency of the ultrasound transducer emitting the ultrasound energy.
  • 2. The method according to claim 1 further comprising monitoring a voltage of power driving the ultrasound transducer over time;communicating the voltage to the controller; andcorrecting the frequency to the specific frequency upon a change of voltage of the power driving the ultrasound transducer.
  • 3. The method according to claim further comprising terminating the emitting ultrasound energy upon a change of the power level above a predetermined power level threshold.
  • 4. The method according to claim 1 further comprising terminating the emitting ultrasound energy when the temperature of the ultrasound transducer is above a predetermined temperature threshold.
  • 5. The method according to claim 1 further comprising terminating the emitting ultrasound energy when the temperature of the ultrasound transducer is below a predetermined temperature threshold.
  • 6. The method according to claim 1 further comprising monitoring the power driving the ultrasound transducer over time;communicating the voltage to the controller; andterminating the emitting ultrasound energy when the voltage of the power driving the ultrasound transducer is above a predetermined voltage threshold.
  • 7. The method according to claim 1 further comprising monitoring a voltage of the power driving the ultrasound transducer over time;communicating the voltage to the controller; andterminating the emitting ultrasound energy when the voltage of the power driving the ultrasound transducer is below a predetermined voltage threshold.
  • 8. The method according to claim 1 wherein correcting the ultrasound energy to the specific frequency lowers the temperature of the ultrasound transducer.
  • 9. The method according to claim 1 farther comprising modifying the temperature of the ultrasound transducer to stay within the predetermined temperature range.
  • 10. A method of providing ultrasound energy having a stable power output, the method comprising: providing ultrasound energy at a center frequency from an ultrasound transducer at a predetermined voltage;monitoring a voltage level of power driving the ultrasound transducer over time;communicating the voltage level to a Controller;correcting the ultrasound energy to the center frequency upon a change in the voltage level of the power driving the ultrasound transducer, as compared to the predetermined voltage;monitoring a temperature of the ultrasound transducer over time;communicating the temperature to the controller; andpreventing a shift in the frequency of the ultrasound energy away from the center frequency upon a change in the temperature of the ultrasound transducer over time;thereby maximizing efficiency of the ultrasound transducer emitting the ultrasound energy.
  • 11. The method according to claim 10 further comprising; monitoring a power level to the ultrasound transducer over time;communicating the power level to the controller; andcorrecting the ultrasound energy hack to the center frequency upon a change of the power level to the transducer.
  • 12. The method according to claim 10 further comprising terminating the providing ultrasound energy upon a change of the voltage level of the power driving the ultrasound transducer is above a predetermined voltage level threshold.
  • 13. The method according to claim 10, further comprising terminating the emitting ultrasound energy when the voltage level of the power driving the ultrasound transducer is below a predetermined voltage level threshold.
  • 14. The method according to claim 10 further comprising terminating the providing ultrasound energy upon a change of the voltage level of the power driving the ultrasound transducer is below a predetermined voltage level threshold.
  • 15. The method according to claim 10 further comprising terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above a predetermined temperature threshold.
  • 16. The method according to claim 10 further comprising terminating the providing the ultrasound energy when the temperature of the ultrasound transducer is below a predetermined temperature threshold.
  • 17. The method according to claim 10 further comprising terminating the providing the ultrasound energy when the voltage level of the ultrasound transducer is above a predetermined voltage threshold.
  • 18. The method according to claim 10 wherein correcting the ultrasound energy to the center frequency lowers the voltage level of the power driving the ultrasound transducer or lowers the temperature of the ultrasound transducer.
  • 19. The method according to claim 10 further comprising preventing a change in impedance of the ultrasound transducer.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 61/506,609, entitled “Systems and Methods for Monitoring Ultrasound Power Efficiency,” filed Jul. 11, 2011; and U.S. Provisional Patent Application Ser. No. 61/506,610, entitled “Methods and Systems for Controlling Acoustic Energy Deposition into a Medium,” filed Jul. 11, 2011; all of which are incorporated by reference herein.

US Referenced Citations (825)
Number Name Date Kind
2427348 Bond et al. Sep 1947 A
3913386 Saglio Oct 1975 A
3965455 Hurwitz Jun 1976 A
3992925 Perilhou Nov 1976 A
4039312 Patru Aug 1977 A
4059098 Murdock Nov 1977 A
4101795 Fukumoto Jul 1978 A
4166967 Benes et al. Sep 1979 A
4211948 Brisken et al. Jul 1980 A
4211949 Brisken et al. Jul 1980 A
4213344 Rose Jul 1980 A
4276491 Daniel Jun 1981 A
4315514 Drewes et al. Feb 1982 A
4325381 Glenn Apr 1982 A
4343301 Indech Aug 1982 A
4372296 Fahim Feb 1983 A
4379145 Masuho et al. Apr 1983 A
4381007 Doss Apr 1983 A
4381787 Hottinger May 1983 A
4397314 Vaguine Aug 1983 A
4409839 Taenzer Oct 1983 A
4431008 Wanner et al. Feb 1984 A
4441486 Pounds Apr 1984 A
4452084 Taenzer Jun 1984 A
4484569 Driller et al. Nov 1984 A
4507582 Glenn Mar 1985 A
4513749 Kino et al. Apr 1985 A
4513750 Heyman et al. Apr 1985 A
4527550 Ruggera et al. Jul 1985 A
4528979 Marchenko et al. Jul 1985 A
4534221 Fife et al. Aug 1985 A
4566459 Umemura et al. Jan 1986 A
4567895 Putzke Feb 1986 A
4586512 Do-huu May 1986 A
4601296 Yerushalmi Jul 1986 A
4620546 Aida et al. Nov 1986 A
4637256 Sugiyama et al. Jan 1987 A
4646756 Watmough Mar 1987 A
4663358 Hyon May 1987 A
4668516 Duraffourd et al. May 1987 A
4672591 Breimesser et al. Jun 1987 A
4680499 Umemura et al. Jul 1987 A
4697588 Reichenberger Oct 1987 A
4754760 Fukukita et al. Jul 1988 A
4757820 Itoh Jul 1988 A
4771205 Mequio Sep 1988 A
4801459 Liburdy Jan 1989 A
4803625 Fu et al. Feb 1989 A
4807633 Fry Feb 1989 A
4817615 Fukukita et al. Apr 1989 A
4858613 Fry Aug 1989 A
4860732 Hasegawa et al. Aug 1989 A
4865041 Hassler Sep 1989 A
4865042 Umemura Sep 1989 A
4867169 Machida Sep 1989 A
4874562 Hyon Oct 1989 A
4875487 Seppi Oct 1989 A
4891043 Zeimer et al. Jan 1990 A
4893624 Lele Jan 1990 A
4896673 Rose Jan 1990 A
4900540 Ryan et al. Feb 1990 A
4901729 Saitoh et al. Feb 1990 A
D306965 Jaworski Apr 1990 S
4917096 Englehart Apr 1990 A
4932414 Coleman et al. Jun 1990 A
4938216 Lele Jul 1990 A
4938217 Lele Jul 1990 A
4947046 Kawabata et al. Aug 1990 A
4951653 Fry Aug 1990 A
4955365 Fry Sep 1990 A
4958626 Nambu Sep 1990 A
4976709 Sand Dec 1990 A
4979501 Valchanov Dec 1990 A
4992989 Watanabe et al. Feb 1991 A
5012797 Liang May 1991 A
5018508 Fry et al. May 1991 A
5030874 Saito et al. Jul 1991 A
5036855 Fry Aug 1991 A
5040537 Katakura Aug 1991 A
5054310 Flynn Oct 1991 A
5054470 Fry Oct 1991 A
5070879 Herres Dec 1991 A
5088495 Miyagawa Feb 1992 A
5115814 Griffith May 1992 A
5117832 Sanghvi Jun 1992 A
5123418 Saurel Jun 1992 A
5143063 Fellner Sep 1992 A
5143074 Dory Sep 1992 A
5149319 Unger Sep 1992 A
5150711 Dory Sep 1992 A
5150714 Green Sep 1992 A
5152294 Mochizuki et al. Oct 1992 A
5156144 Iwasaki Oct 1992 A
5158536 Sekins Oct 1992 A
5159931 Pini Nov 1992 A
5163421 Bernstein Nov 1992 A
5163436 Saitoh et al. Nov 1992 A
5178135 Uchiyama et al. Jan 1993 A
5190518 Takasu Mar 1993 A
5190766 Ishihara Mar 1993 A
5191880 McLeod Mar 1993 A
5205287 Erbel et al. Apr 1993 A
5209720 Unger May 1993 A
5212671 Fujii et al. May 1993 A
5215680 D Arrigo Jun 1993 A
5224467 Oku Jul 1993 A
5230334 Klopotek Jul 1993 A
5230338 Allen et al. Jul 1993 A
5247924 Suzuki et al. Sep 1993 A
5255681 Ishimura et al. Oct 1993 A
5257970 Dougherty Nov 1993 A
5265614 Hayakawa Nov 1993 A
5267985 Shimada et al. Dec 1993 A
5269297 Weng Dec 1993 A
5282797 Chess Feb 1994 A
5295484 Marcus Mar 1994 A
5295486 Wollschlager et al. Mar 1994 A
5304169 Sand Apr 1994 A
5305756 Entrekin et al. Apr 1994 A
5321520 Inga et al. Jun 1994 A
5323779 Hardy et al. Jun 1994 A
5327895 Hashimoto et al. Jul 1994 A
5348016 Unger et al. Sep 1994 A
5360268 Hayashi Nov 1994 A
5370121 Reichenberger Dec 1994 A
5371483 Bhardwaj Dec 1994 A
5375602 Lancee et al. Dec 1994 A
5379773 Hornsby Jan 1995 A
5380280 Peterson Jan 1995 A
5380519 Schneider et al. Jan 1995 A
5383917 Desai et al. Jan 1995 A
5391140 Schaetzle Feb 1995 A
5391197 Burdette et al. Feb 1995 A
5392259 Bolorforosh Feb 1995 A
5396143 Seyed-Bolorforosh et al. Mar 1995 A
5398689 Connor et al. Mar 1995 A
5406503 Williams, Jr. et al. Apr 1995 A
5417216 Tanaka May 1995 A
5419327 Rohwedder May 1995 A
5423220 Finsterwald et al. Jun 1995 A
5435311 Umemura Jul 1995 A
5438998 Hanafy Aug 1995 A
5458596 Lax Oct 1995 A
5460179 Okunuki et al. Oct 1995 A
5460595 Hall et al. Oct 1995 A
5469854 Unger et al. Nov 1995 A
5471988 Fujio Dec 1995 A
5487388 Rello et al. Jan 1996 A
5492126 Hennige Feb 1996 A
5496256 Bock Mar 1996 A
5501655 Rolt Mar 1996 A
5503152 Oakley et al. Apr 1996 A
5503320 Webster et al. Apr 1996 A
5507790 Weiss Apr 1996 A
5520188 Hennige May 1996 A
5522869 Burdette Jun 1996 A
5523058 Umemura et al. Jun 1996 A
5524620 Rosenschein Jun 1996 A
5524624 Tepper Jun 1996 A
5524625 Okazaki et al. Jun 1996 A
5526624 Berg Jun 1996 A
5526812 Dumoulin et al. Jun 1996 A
5526814 Cline et al. Jun 1996 A
5526815 Granz Jun 1996 A
5529070 Augustine et al. Jun 1996 A
5540235 Wilson Jul 1996 A
5558092 Unger Sep 1996 A
5560362 Sliwa et al. Oct 1996 A
5575291 Hayakawa Nov 1996 A
5575807 Faller Nov 1996 A
5577502 Darrow et al. Nov 1996 A
5577507 Snyder et al. Nov 1996 A
5577991 Akui et al. Nov 1996 A
5580575 Unger et al. Dec 1996 A
5601526 Chapelon Feb 1997 A
5603323 Pflugrath et al. Feb 1997 A
5609562 Kaali Mar 1997 A
5615091 Palatnik Mar 1997 A
5617858 Taverna et al. Apr 1997 A
5618275 Bock Apr 1997 A
5620479 Diederich Apr 1997 A
5622175 Sudol et al. Apr 1997 A
5638819 Manwaring et al. Jun 1997 A
5643179 Fujimoto Jul 1997 A
5644085 Lorraine et al. Jul 1997 A
5647373 Paltieli Jul 1997 A
5655535 Friemel et al. Aug 1997 A
5655538 Lorraine Aug 1997 A
5657760 Ying Aug 1997 A
5658328 Johnson Aug 1997 A
5660836 Knowlton Aug 1997 A
5662116 Kondo et al. Sep 1997 A
5665053 Jacobs Sep 1997 A
5665141 Vago Sep 1997 A
5671746 Dreschel et al. Sep 1997 A
5673699 Trahey et al. Oct 1997 A
5676692 Sanghvi Oct 1997 A
5685820 Riek et al. Nov 1997 A
5687737 Branham et al. Nov 1997 A
5690608 Watanabe Nov 1997 A
5694936 Fujimoto Dec 1997 A
5697897 Buchholtz Dec 1997 A
5701900 Shehada et al. Dec 1997 A
5704361 Seward et al. Jan 1998 A
5706252 Le Verrier et al. Jan 1998 A
5706564 Rhyne Jan 1998 A
5715823 Wood et al. Feb 1998 A
5720287 Chapelon et al. Feb 1998 A
5722411 Suzuki Mar 1998 A
5727554 Kalend et al. Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5743863 Chapelon Apr 1998 A
5746005 Steinberg May 1998 A
5746762 Bass May 1998 A
5748767 Raab May 1998 A
5749364 Sliwa et al. May 1998 A
5755228 Wilson et al. May 1998 A
5755753 Knowlton May 1998 A
5762066 Law Jun 1998 A
5763886 Schulte Jun 1998 A
5769790 Watkins Jun 1998 A
5779644 Eberle et al. Jul 1998 A
5792058 Lee et al. Aug 1998 A
5795297 Daigle Aug 1998 A
5795311 Wess Aug 1998 A
5810009 Mine et al. Sep 1998 A
5810888 Fenn Sep 1998 A
5814599 Mitragotri et al. Sep 1998 A
5817013 Ginn et al. Oct 1998 A
5817021 Reichenberger Oct 1998 A
5820564 Slayton Oct 1998 A
5823962 Schaetzle Oct 1998 A
5827204 Grandia et al. Oct 1998 A
5839751 Lutz Nov 1998 A
5840032 Hatfield et al. Nov 1998 A
5844140 Seale Dec 1998 A
5853367 Chalek et al. Dec 1998 A
5869751 Bonin Feb 1999 A
5871524 Knowlton Feb 1999 A
5873902 Sanghvi Feb 1999 A
5876431 Spehr et al. Mar 1999 A
5879303 Averkiou et al. Mar 1999 A
5882557 Hayakawa Mar 1999 A
5891034 Bucholz Apr 1999 A
5899861 Friemel et al. May 1999 A
5904659 Duarte May 1999 A
5919219 Knowlton Jul 1999 A
5923099 Bilir Jul 1999 A
5924989 Polz Jul 1999 A
5928169 Schatzle et al. Jul 1999 A
5931805 Brisken Aug 1999 A
5938606 Bonnefous Aug 1999 A
5938612 Kline-Schoder Aug 1999 A
5948011 Knowlton Sep 1999 A
5957844 Dekel Sep 1999 A
5957882 Nita et al. Sep 1999 A
5957941 Ream Sep 1999 A
5967980 Ferre et al. Oct 1999 A
5968034 Fullmer Oct 1999 A
5971949 Levin Oct 1999 A
5977538 Unger et al. Nov 1999 A
5984882 Rosenschein Nov 1999 A
5990598 Sudol et al. Nov 1999 A
5997471 Gumb et al. Dec 1999 A
5997497 Nita et al. Dec 1999 A
5999843 Anbar Dec 1999 A
6004262 Putz et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6013032 Savord Jan 2000 A
6016255 Bolan et al. Jan 2000 A
6019724 Gronningsaeter et al. Feb 2000 A
6022308 Williams Feb 2000 A
6022327 Chang Feb 2000 A
6036646 Barthe Mar 2000 A
6039048 Silberg Mar 2000 A
6039689 Lizzi Mar 2000 A
6042556 Beach et al. Mar 2000 A
6049159 Barthe Apr 2000 A
6050943 Slayton Apr 2000 A
6059727 Fowlkes May 2000 A
6071239 Cribbs Jun 2000 A
6080108 Dunham Jun 2000 A
6083148 Williams Jul 2000 A
6086535 Ishibashi Jul 2000 A
6086580 Mordon et al. Jul 2000 A
6090054 Tagishi Jul 2000 A
6093883 Sanghvi Jul 2000 A
6101407 Groezinger Aug 2000 A
6106469 Suzuki et al. Aug 2000 A
6113558 Rosenschein Sep 2000 A
6113559 Klopotek Sep 2000 A
6120452 Barthe Sep 2000 A
6123081 Durette Sep 2000 A
6126619 Peterson et al. Oct 2000 A
6135971 Hutchinson et al. Oct 2000 A
6139499 Wilk Oct 2000 A
6159150 Yale et al. Dec 2000 A
6171244 Finger et al. Jan 2001 B1
6176840 Nishimura Jan 2001 B1
6183426 Akisada Feb 2001 B1
6183502 Takeuchi Feb 2001 B1
6183773 Anderson Feb 2001 B1
6190323 Dias et al. Feb 2001 B1
6190336 Duarte Feb 2001 B1
6193658 Wendelken et al. Feb 2001 B1
6210327 Brackett et al. Apr 2001 B1
6213948 Barthe Apr 2001 B1
6216029 Paltieli Apr 2001 B1
6233476 Strommer et al. May 2001 B1
6234990 Rowe et al. May 2001 B1
6241753 Knowlton Jun 2001 B1
6246898 Vesely et al. Jun 2001 B1
6251074 Averkiou et al. Jun 2001 B1
6251088 Kaufman et al. Jun 2001 B1
6268405 Yao Jul 2001 B1
6273864 Duarte Aug 2001 B1
6280402 Ishibashi et al. Aug 2001 B1
6287257 Matichuk Sep 2001 B1
6296619 Brisken Oct 2001 B1
6301989 Brown et al. Oct 2001 B1
6309355 Cain et al. Oct 2001 B1
6311090 Knowlton Oct 2001 B1
6315741 Martin Nov 2001 B1
6322509 Pan et al. Nov 2001 B1
6322532 D'Sa Nov 2001 B1
6325540 Lounsberry et al. Dec 2001 B1
6325758 Carol et al. Dec 2001 B1
6325769 Klopotek Dec 2001 B1
6325798 Edwards et al. Dec 2001 B1
6338716 Hossack et al. Jan 2002 B1
6350276 Knowlton Feb 2002 B1
6356780 Licato et al. Mar 2002 B1
6361531 Hissong Mar 2002 B1
6370411 Osadchy et al. Apr 2002 B1
6375672 Aksan Apr 2002 B1
6377854 Knowlton Apr 2002 B1
6377855 Knowlton Apr 2002 B1
6381497 Knowlton Apr 2002 B1
6381498 Knowlton Apr 2002 B1
6387380 Knowlton May 2002 B1
6390982 Bova et al. May 2002 B1
6405090 Knowlton Jun 2002 B1
6409720 Hissong Jun 2002 B1
6413216 Cain et al. Jul 2002 B1
6413253 Koop Jul 2002 B1
6413254 Hissong Jul 2002 B1
6419648 Vitek Jul 2002 B1
6423007 Lizzi et al. Jul 2002 B2
6425865 Salcudean Jul 2002 B1
6425867 Vaezy Jul 2002 B1
6425912 Knowlton Jul 2002 B1
6428477 Mason Aug 2002 B1
6428532 Doukas Aug 2002 B1
6430446 Knowlton Aug 2002 B1
6432057 Mazess et al. Aug 2002 B1
6432067 Martin Aug 2002 B1
6432101 Weber Aug 2002 B1
6436061 Costantino Aug 2002 B1
6438424 Knowlton Aug 2002 B1
6440071 Slayton Aug 2002 B1
6440121 Weber Aug 2002 B1
6443914 Costantino Sep 2002 B1
6453202 Knowlton Sep 2002 B1
6461378 Knowlton Oct 2002 B1
6470216 Knowlton Oct 2002 B1
6488626 Lizzi et al. Dec 2002 B1
6491657 Rowe Dec 2002 B2
6500121 Slayton Dec 2002 B1
6500141 Irion Dec 2002 B1
6508774 Acker Jan 2003 B1
6511427 Sliwa, Jr. et al. Jan 2003 B1
6511428 Azuma Jan 2003 B1
6514244 Pope Feb 2003 B2
6517484 Wilk et al. Feb 2003 B1
6524250 Weber Feb 2003 B1
6540679 Slayton Apr 2003 B2
6540685 Rhoads et al. Apr 2003 B1
6540700 Fujimoto et al. Apr 2003 B1
6554771 Buil et al. Apr 2003 B1
6569099 Babaev May 2003 B1
6569108 Sarvazyan et al. May 2003 B2
6572552 Fukukita Jun 2003 B2
6575956 Brisken et al. Jun 2003 B1
6595934 Hissong Jul 2003 B1
6599256 Acker Jul 2003 B1
6607498 Eshel Aug 2003 B2
6618620 Freundlich et al. Sep 2003 B1
6623430 Slayton Sep 2003 B1
6626854 Friedman Sep 2003 B2
6626855 Weng Sep 2003 B1
6638226 He et al. Oct 2003 B2
6645162 Friedman Nov 2003 B2
6662054 Kreindel Dec 2003 B2
6663627 Francischelli Dec 2003 B2
6665806 Shimizu Dec 2003 B1
6666835 Martin Dec 2003 B2
6669638 Miller et al. Dec 2003 B1
6685640 Fry Feb 2004 B1
6692450 Coleman Feb 2004 B1
6699237 Weber Mar 2004 B2
6716184 Vaezy et al. Apr 2004 B2
6719449 Laugharn Apr 2004 B1
6719694 Weng Apr 2004 B2
6726627 Lizzi et al. Apr 2004 B1
6733449 Krishnamurthy et al. May 2004 B1
6749624 Knowlton Jun 2004 B2
6773409 Truckai et al. Aug 2004 B2
6775404 Pagoulatos et al. Aug 2004 B1
6790187 Thompson et al. Sep 2004 B2
6824516 Batten et al. Nov 2004 B2
6825176 White et al. Nov 2004 B2
6835940 Morikawa et al. Dec 2004 B2
6846290 Lizzi et al. Jan 2005 B2
6875176 Mourad et al. Apr 2005 B2
6882884 Mosk et al. Apr 2005 B1
6887239 Elstrom May 2005 B2
6889089 Behl May 2005 B2
6896657 Willis May 2005 B2
6902536 Manna Jun 2005 B2
6905466 Salgo Jun 2005 B2
6918907 Kelly Jul 2005 B2
6920883 Bessette Jul 2005 B2
6921371 Wilson Jul 2005 B2
6932771 Whitmore Aug 2005 B2
6932814 Wood Aug 2005 B2
6936044 McDaniel Aug 2005 B2
6936046 Hissong Aug 2005 B2
6945937 Culp et al. Sep 2005 B2
6948843 Laugharn et al. Sep 2005 B2
6953941 Nakano et al. Oct 2005 B2
6958043 Hissong Oct 2005 B2
6971994 Young et al. Dec 2005 B1
6974417 Lockwood Dec 2005 B2
6976492 Ingle Dec 2005 B2
6992305 Maezawa et al. Jan 2006 B2
6997923 Anderson Feb 2006 B2
7006874 Knowlton Feb 2006 B2
7020528 Neev Mar 2006 B2
7022089 Ooba Apr 2006 B2
7058440 Heuscher et al. Jun 2006 B2
7063666 Weng Jun 2006 B2
7070565 Vaezy et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7094252 Koop Aug 2006 B2
7108663 Talish et al. Sep 2006 B2
7115123 Knowlton Oct 2006 B2
7122029 Koop et al. Oct 2006 B2
7142905 Slayton Nov 2006 B2
7165451 Brooks et al. Jan 2007 B1
7179238 Hissong Feb 2007 B2
7189230 Knowlton Mar 2007 B2
7229411 Slayton Jun 2007 B2
7235592 Muratoglu Jun 2007 B2
7258674 Cribbs Aug 2007 B2
7273459 Desilets Sep 2007 B2
7294125 Phalen et al. Nov 2007 B2
7297117 Trucco et al. Nov 2007 B2
7303555 Makin et al. Dec 2007 B2
7327071 Nishiyama et al. Feb 2008 B2
7331951 Eshel et al. Feb 2008 B2
7332985 Larson, III et al. Feb 2008 B2
7347855 Eshel Mar 2008 B2
RE40403 Cho et al. Jun 2008 E
7393325 Barthe Jul 2008 B2
7398116 Edwards Jul 2008 B2
7399279 Abend et al. Jul 2008 B2
7491171 Barthe et al. Feb 2009 B2
7510536 Foley et al. Mar 2009 B2
7530356 Slayton May 2009 B2
7530958 Slayton May 2009 B2
7571336 Barthe Aug 2009 B2
7601120 Moilanen et al. Oct 2009 B2
7615015 Coleman Nov 2009 B2
7615016 Barthe Nov 2009 B2
7686763 Vaezy et al. Mar 2010 B2
7695437 Quistgaard et al. Apr 2010 B2
7758524 Barthe Jul 2010 B2
7789841 Huckle et al. Sep 2010 B2
7824348 Barthe et al. Nov 2010 B2
7846096 Mast et al. Dec 2010 B2
7857773 Desilets et al. Dec 2010 B2
7875023 Eshel et al. Jan 2011 B2
7914453 Slayton et al. Mar 2011 B2
7914469 Torbati Mar 2011 B2
7931611 Novak et al. Apr 2011 B2
7955281 Pedersen et al. Jun 2011 B2
7967764 Lidgren et al. Jun 2011 B2
7967839 Flock et al. Jun 2011 B2
8057389 Barthe et al. Nov 2011 B2
8057465 Sliwa, Jr. et al. Nov 2011 B2
8066641 Barthe et al. Nov 2011 B2
8123707 Huckle et al. Feb 2012 B2
8128618 Gliklich et al. Mar 2012 B2
8133180 Slayton et al. Mar 2012 B2
8133191 Rosenberg et al. Mar 2012 B2
8166332 Barthe et al. Apr 2012 B2
8197409 Foley et al. Jun 2012 B2
8206299 Foley et al. Jun 2012 B2
8211017 Foley et al. Jul 2012 B2
8262591 Pedersen et al. Sep 2012 B2
8273037 Kreindel et al. Sep 2012 B2
8282554 Makin et al. Oct 2012 B2
8333700 Barthe et al. Dec 2012 B1
8366622 Slayton et al. Feb 2013 B2
8409097 Slayton et al. Apr 2013 B2
8444562 Barthe et al. May 2013 B2
8480585 Slayton et al. Jul 2013 B2
8506486 Slayton et al. Aug 2013 B2
8523775 Barthe et al. Sep 2013 B2
8535228 Slayton et al. Sep 2013 B2
8585618 Hunziker et al. Nov 2013 B2
8636665 Slayton et al. Jan 2014 B2
8641622 Barthe et al. Feb 2014 B2
8663112 Slayton et al. Mar 2014 B2
8672848 Slayton et al. Mar 2014 B2
8690778 Slayton et al. Apr 2014 B2
8690779 Slayton et al. Apr 2014 B2
8690780 Slayton et al. Apr 2014 B2
8708935 Barthe et al. Apr 2014 B2
8715186 Slayton et al. May 2014 B2
8726781 Eckhoff et al. May 2014 B2
20010009997 Pope Jul 2001 A1
20010009999 Kaufman et al. Jul 2001 A1
20010014780 Martin et al. Aug 2001 A1
20010014819 Ingle et al. Aug 2001 A1
20010031922 Weng et al. Oct 2001 A1
20010039380 Larson et al. Nov 2001 A1
20010041880 Brisken Nov 2001 A1
20020000763 Jones Jan 2002 A1
20020002345 Marlinghaus Jan 2002 A1
20020040199 Klopotek Apr 2002 A1
20020040442 Ishidera Apr 2002 A1
20020052550 Madsen et al. May 2002 A1
20020055702 Atala May 2002 A1
20020062077 Emmenegger et al. May 2002 A1
20020062142 Knowlton May 2002 A1
20020072691 Thompson et al. Jun 2002 A1
20020082528 Friedman et al. Jun 2002 A1
20020082529 Suorsa et al. Jun 2002 A1
20020082589 Friedman et al. Jun 2002 A1
20020087080 Slayton et al. Jul 2002 A1
20020095143 Key Jul 2002 A1
20020099094 Anderson Jul 2002 A1
20020115917 Honda et al. Aug 2002 A1
20020128648 Weber Sep 2002 A1
20020143252 Dunne et al. Oct 2002 A1
20020156400 Babaev Oct 2002 A1
20020161357 Anderson Oct 2002 A1
20020165529 Danek Nov 2002 A1
20020168049 Schriever Nov 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020169442 Neev Nov 2002 A1
20020173721 Grunwald et al. Nov 2002 A1
20020193784 McHale et al. Dec 2002 A1
20020193831 Smith Dec 2002 A1
20030009153 Brisken et al. Jan 2003 A1
20030014039 Barzell et al. Jan 2003 A1
20030018255 Martin Jan 2003 A1
20030028111 Vaezy et al. Feb 2003 A1
20030028113 Gilbert et al. Feb 2003 A1
20030032900 Ella Feb 2003 A1
20030036706 Slayton et al. Feb 2003 A1
20030040442 Yokouchi Feb 2003 A1
20030040739 Koop Feb 2003 A1
20030050678 Sierra Mar 2003 A1
20030055417 Truckai et al. Mar 2003 A1
20030060736 Martin et al. Mar 2003 A1
20030065313 Koop Apr 2003 A1
20030074023 Kaplan Apr 2003 A1
20030083536 Eshel May 2003 A1
20030092988 Makin May 2003 A1
20030097071 Halmann et al. May 2003 A1
20030099383 Lefebvre May 2003 A1
20030125629 Ustuner Jul 2003 A1
20030139790 Ingle et al. Jul 2003 A1
20030171678 Batten et al. Sep 2003 A1
20030171701 Babaev Sep 2003 A1
20030176790 Slayton Sep 2003 A1
20030191396 Sanghvi Oct 2003 A1
20030200481 Stanley Oct 2003 A1
20030212129 Liu et al. Nov 2003 A1
20030212351 Hissong Nov 2003 A1
20030212393 Knowlton Nov 2003 A1
20030216795 Harth Nov 2003 A1
20030220536 Hissong Nov 2003 A1
20030220585 Hissong Nov 2003 A1
20030229331 Brisken et al. Dec 2003 A1
20030233085 Giammarusti Dec 2003 A1
20030236487 Knowlton Dec 2003 A1
20040000316 Knowlton Jan 2004 A1
20040001809 Brisken Jan 2004 A1
20040002705 Knowlton Jan 2004 A1
20040010222 Nunomura et al. Jan 2004 A1
20040015106 Coleman Jan 2004 A1
20040030227 Littrup Feb 2004 A1
20040039312 Hillstead Feb 2004 A1
20040039418 Elstrom et al. Feb 2004 A1
20040041563 Lewin et al. Mar 2004 A1
20040041880 Ikeda et al. Mar 2004 A1
20040042168 Yang et al. Mar 2004 A1
20040044375 Diederich et al. Mar 2004 A1
20040049134 Tosaya et al. Mar 2004 A1
20040049734 Simske Mar 2004 A1
20040059266 Fry Mar 2004 A1
20040068186 Ishida et al. Apr 2004 A1
20040073079 Altshuler et al. Apr 2004 A1
20040073113 Salgo Apr 2004 A1
20040073115 Horzewski et al. Apr 2004 A1
20040073116 Smith Apr 2004 A1
20040073204 Ryan et al. Apr 2004 A1
20040077977 Ella et al. Apr 2004 A1
20040082857 Schonenberger et al. Apr 2004 A1
20040082859 Schaer Apr 2004 A1
20040102697 Evron May 2004 A1
20040105559 Aylward et al. Jun 2004 A1
20040122323 Vortman et al. Jun 2004 A1
20040122493 Ishibashi et al. Jun 2004 A1
20040143297 Ramsey Jul 2004 A1
20040152982 Hwang et al. Aug 2004 A1
20040158150 Rabiner et al. Aug 2004 A1
20040186535 Knowlton Sep 2004 A1
20040189155 Funakubo Sep 2004 A1
20040206365 Knowlton Oct 2004 A1
20040210214 Knowlton Oct 2004 A1
20040217675 Desilets Nov 2004 A1
20040249318 Tanaka Dec 2004 A1
20040254620 Lacoste et al. Dec 2004 A1
20040267252 Washington et al. Dec 2004 A1
20050033201 Takahashi Feb 2005 A1
20050033316 Kertz Feb 2005 A1
20050038340 Vaezy et al. Feb 2005 A1
20050055073 Weber Mar 2005 A1
20050061834 Garcia et al. Mar 2005 A1
20050070961 Maki et al. Mar 2005 A1
20050074407 Smith Apr 2005 A1
20050080469 Larson Apr 2005 A1
20050091770 Mourad et al. May 2005 A1
20050096542 Weng et al. May 2005 A1
20050104690 Larson, III et al. May 2005 A1
20050113689 Gritzky May 2005 A1
20050134314 Prather et al. Jun 2005 A1
20050137656 Malak Jun 2005 A1
20050143677 Young et al. Jun 2005 A1
20050154313 Desilets Jul 2005 A1
20050154314 Quistgaard Jul 2005 A1
20050154332 Zanelli Jul 2005 A1
20050154431 Quistgaard Jul 2005 A1
20050187495 Quistgaard Aug 2005 A1
20050191252 Mitsui Sep 2005 A1
20050193451 Quistgaard et al. Sep 2005 A1
20050197681 Barolet et al. Sep 2005 A1
20050228281 Nefos Oct 2005 A1
20050240170 Zhang et al. Oct 2005 A1
20050251120 Anderson et al. Nov 2005 A1
20050256406 Barthe Nov 2005 A1
20050261584 Eshel Nov 2005 A1
20050261585 Makin et al. Nov 2005 A1
20050267454 Hissong Dec 2005 A1
20050288748 Li et al. Dec 2005 A1
20060004306 Altshuler Jan 2006 A1
20060020260 Dover et al. Jan 2006 A1
20060025756 Francischelli Feb 2006 A1
20060042201 Curry Mar 2006 A1
20060058664 Barthe Mar 2006 A1
20060058671 Vitek et al. Mar 2006 A1
20060058707 Barthe Mar 2006 A1
20060058712 Altshuler et al. Mar 2006 A1
20060074309 Bonnefous Apr 2006 A1
20060074313 Slayton et al. Apr 2006 A1
20060074314 Slayton Apr 2006 A1
20060074355 Slayton Apr 2006 A1
20060079816 Barthe Apr 2006 A1
20060079868 Makin Apr 2006 A1
20060084891 Barthe Apr 2006 A1
20060089632 Barthe Apr 2006 A1
20060089688 Panescu Apr 2006 A1
20060094988 Tosaya et al. May 2006 A1
20060111744 Makin May 2006 A1
20060116583 Ogasawara et al. Jun 2006 A1
20060116671 Slayton Jun 2006 A1
20060122508 Slayton Jun 2006 A1
20060122509 Desilets Jun 2006 A1
20060161062 Arditi Jul 2006 A1
20060184069 Vaitekunas Aug 2006 A1
20060184071 Klopotek Aug 2006 A1
20060189972 Grossman Aug 2006 A1
20060206105 Chopra Sep 2006 A1
20060229514 Wiener Oct 2006 A1
20060241440 Eshel Oct 2006 A1
20060241442 Barthe Oct 2006 A1
20060241470 Novak et al. Oct 2006 A1
20060250046 Koizumi et al. Nov 2006 A1
20060261584 Blackburn Nov 2006 A1
20060282691 Barthe Dec 2006 A1
20060291710 Wang et al. Dec 2006 A1
20070032784 Gliklich et al. Feb 2007 A1
20070035201 Desilets Feb 2007 A1
20070055154 Torbati Mar 2007 A1
20070055155 Owen et al. Mar 2007 A1
20070055156 Desilets et al. Mar 2007 A1
20070065420 Johnson Mar 2007 A1
20070083120 Cain et al. Apr 2007 A1
20070087060 Dietrich Apr 2007 A1
20070088245 Babaev et al. Apr 2007 A1
20070088346 Mirizzi et al. Apr 2007 A1
20070161902 Dan Jul 2007 A1
20070166357 Shaffer et al. Jul 2007 A1
20070167709 Slayton Jul 2007 A1
20070208253 Slayton Sep 2007 A1
20070219604 Yaroslavsky et al. Sep 2007 A1
20070219605 Yaroslavsky et al. Sep 2007 A1
20070238994 Stecco et al. Oct 2007 A1
20070239075 Rosenberg et al. Oct 2007 A1
20070239079 Manstein et al. Oct 2007 A1
20070239142 Altshuler et al. Oct 2007 A1
20080027328 Klopotek et al. Jan 2008 A1
20080039724 Seip et al. Feb 2008 A1
20080071255 Barthe Mar 2008 A1
20080086054 Slayton Apr 2008 A1
20080097253 Pedersen Apr 2008 A1
20080139974 Da Silva Jun 2008 A1
20080146970 Litman et al. Jun 2008 A1
20080167556 Thompson et al. Jul 2008 A1
20080183077 Moreau-Gobard et al. Jul 2008 A1
20080188745 Chen et al. Aug 2008 A1
20080195000 Spooner et al. Aug 2008 A1
20080200810 Buchalter Aug 2008 A1
20080200813 Quistgaard Aug 2008 A1
20080214966 Slayton Sep 2008 A1
20080221491 Slayton Sep 2008 A1
20080223379 Stuker et al. Sep 2008 A1
20080243035 Crunkilton Oct 2008 A1
20080269608 Anderson et al. Oct 2008 A1
20080275342 Barthe Nov 2008 A1
20080281206 Bartlett et al. Nov 2008 A1
20080281236 Eshel et al. Nov 2008 A1
20080281237 Slayton Nov 2008 A1
20080281255 Slayton Nov 2008 A1
20080294073 Barthe Nov 2008 A1
20080319356 Cain et al. Dec 2008 A1
20090005680 Jones et al. Jan 2009 A1
20090012394 Hobelsberger et al. Jan 2009 A1
20090043198 Milner et al. Feb 2009 A1
20090043293 Pankratov et al. Feb 2009 A1
20090069677 Chen et al. Mar 2009 A1
20090093737 Chomas et al. Apr 2009 A1
20090156969 Santangelo Jun 2009 A1
20090171252 Bockenstedt et al. Jul 2009 A1
20090177122 Peterson Jul 2009 A1
20090177123 Peterson Jul 2009 A1
20090182231 Barthe et al. Jul 2009 A1
20090216159 Slayton et al. Aug 2009 A1
20090226424 Hsu Sep 2009 A1
20090227910 Pedersen et al. Sep 2009 A1
20090253988 Slayton et al. Oct 2009 A1
20090299175 Bernstein et al. Dec 2009 A1
20090318909 Debenedictis et al. Dec 2009 A1
20100011236 Barthe et al. Jan 2010 A1
20100022919 Peterson Jan 2010 A1
20100022922 Barthe et al. Jan 2010 A1
20100042020 Ben-Ezra Feb 2010 A1
20100049178 Deem et al. Feb 2010 A1
20100063422 Hynynen et al. Mar 2010 A1
20100130891 Taggart et al. May 2010 A1
20100160782 Slayton et al. Jun 2010 A1
20100160837 Hunziker et al. Jun 2010 A1
20100168576 Poland et al. Jul 2010 A1
20100191120 Kraus et al. Jul 2010 A1
20100241035 Barthe et al. Sep 2010 A1
20100280420 Barthe et al. Nov 2010 A1
20100286518 Lee et al. Nov 2010 A1
20110040171 Foley et al. Feb 2011 A1
20110040190 Jahnke et al. Feb 2011 A1
20110087099 Eshel et al. Apr 2011 A1
20110087255 Mccormack et al. Apr 2011 A1
20110112405 Barthe et al. May 2011 A1
20110178444 Slayton et al. Jul 2011 A1
20110190745 Uebelhoer et al. Aug 2011 A1
20110264012 Lautzenhiser et al. Oct 2011 A1
20120004549 Barthe et al. Jan 2012 A1
20120016239 Barthe et al. Jan 2012 A1
20120029353 Slayton et al. Feb 2012 A1
20120035475 Barthe et al. Feb 2012 A1
20120035476 Barthe et al. Feb 2012 A1
20120046547 Barthe et al. Feb 2012 A1
20120053458 Barthe et al. Mar 2012 A1
20120111339 Barthe et al. May 2012 A1
20120143056 Slayton et al. Jun 2012 A1
20120165668 Slayton et al. Jun 2012 A1
20120165848 Slayton et al. Jun 2012 A1
20120197120 Makin et al. Aug 2012 A1
20120197121 Slayton et al. Aug 2012 A1
20120215105 Slayton et al. Aug 2012 A1
20120271294 Barthe et al. Oct 2012 A1
20120296240 Azhari et al. Nov 2012 A1
20120316426 Foley et al. Dec 2012 A1
20120330197 Makin et al. Dec 2012 A1
20120330222 Barthe et al. Dec 2012 A1
20120330223 Makin et al. Dec 2012 A1
20130012755 Slayton Jan 2013 A1
20130012816 Slayton et al. Jan 2013 A1
20130012838 Jaeger et al. Jan 2013 A1
20130012842 Barthe Jan 2013 A1
20130018286 Slayton et al. Jan 2013 A1
20130046209 Slayton et al. Feb 2013 A1
20130066208 Barthe et al. Mar 2013 A1
20130066237 Smotrich et al. Mar 2013 A1
20130072826 Slayton et al. Mar 2013 A1
20130096471 Slayton et al. Apr 2013 A1
20130190659 Slayton et al. Jul 2013 A1
20130211258 Barthe et al. Aug 2013 A1
20130281853 Slayton et al. Oct 2013 A1
20130281891 Slayton et al. Oct 2013 A1
20130296697 Slayton et al. Nov 2013 A1
20130296700 Slayton et al. Nov 2013 A1
20130303904 Barthe et al. Nov 2013 A1
20130303905 Barthe et al. Nov 2013 A1
20130310863 Barthe et al. Nov 2013 A1
20140082907 Barthe Mar 2014 A1
20140142430 Slayton et al. May 2014 A1
20140148834 Barthe et al. May 2014 A1
20140180174 Slayton et al. Jun 2014 A1
20140187944 Slayton et al. Jul 2014 A1
20140188015 Slayton et al. Jul 2014 A1
20140188145 Slayton et al. Jul 2014 A1
Foreign Referenced Citations (94)
Number Date Country
4029175 Mar 1992 DE
10140064 Mar 2003 DE
10219217 Nov 2003 DE
10219297 Nov 2003 DE
20314479 Mar 2004 DE
0344773 Dec 1989 EP
1479412 Nov 1991 EP
0473553 Apr 1992 EP
0661029 Jul 1995 EP
1050322 Nov 2000 EP
1234566 Aug 2002 EP
1262160 Dec 2002 EP
1374944 Jan 2004 EP
2113099 Aug 1983 GB
63036171 Feb 1988 JP
03048299 Mar 1991 JP
3123559 May 1991 JP
03136642 Jun 1991 JP
4089058 Mar 1992 JP
04150847 May 1992 JP
7080087 Mar 1995 JP
07505793 Jun 1995 JP
7222782 Aug 1995 JP
09047458 Feb 1997 JP
11505440 May 1999 JP
11506636 Jun 1999 JP
2000166940 Jun 2000 JP
2001170068 Jun 2001 JP
2002515786 May 2002 JP
2002521118 Jul 2002 JP
2002537939 Nov 2002 JP
2003050298 Feb 2003 JP
2002078764 Mar 2003 JP
2003204982 Jul 2003 JP
2004147719 May 2004 JP
2005503388 Feb 2005 JP
2005527336 Sep 2005 JP
2005323213 Nov 2005 JP
2006520247 Sep 2006 JP
2007505793 Mar 2007 JP
2009518126 May 2009 JP
2010517695 May 2010 JP
1020010024871 Mar 2001 KR
100400870 Oct 2003 KR
1020060113930 Nov 2006 KR
1020070065332 Jun 2007 KR
1020070070161 Jul 2007 KR
1020070098856 Oct 2007 KR
1020070104878 Oct 2007 KR
1020070114105 Nov 2007 KR
9625888 Aug 1996 WO
9639079 Dec 1996 WO
9735518 Oct 1997 WO
9832379 Jul 1998 WO
9933520 Jul 1999 WO
9949788 Oct 1999 WO
0006032 Feb 2000 WO
0015300 Mar 2000 WO
0021612 Apr 2000 WO
0053113 Sep 2000 WO
0128623 Apr 2001 WO
0182777 Nov 2001 WO
0182778 Nov 2001 WO
0187161 Nov 2001 WO
0209813 Feb 2002 WO
02024050 Mar 2002 WO
02092168 Nov 2002 WO
020292168 Nov 2002 WO
03053266 Jul 2003 WO
03065347 Aug 2003 WO
03070105 Aug 2003 WO
03077833 Aug 2003 WO
03086215 Oct 2003 WO
03096883 Nov 2003 WO
03099177 Dec 2003 WO
03101530 Dec 2003 WO
2004000116 Dec 2003 WO
2004080147 Sep 2004 WO
2004110558 Dec 2004 WO
2005011804 Feb 2005 WO
2005065408 Jul 2005 WO
2005090978 Sep 2005 WO
2006036870 Apr 2006 WO
2006042163 Apr 2006 WO
2006042168 Apr 2006 WO
2006042201 Apr 2006 WO
2006065671 Jun 2006 WO
2006082573 Aug 2006 WO
2007067563 Jun 2007 WO
2008024923 Feb 2008 WO
2008036622 Mar 2008 WO
2009013729 Jan 2009 WO
2009149390 Dec 2009 WO
2014055708 Apr 2014 WO
Non-Patent Literature Citations (67)
Entry
Arthur et al., “Non-invasive estimation of hyperthermia temperatures with ultrasound,” Int. J. Hyperthermia, Sep. 2005, 21(6), pp. 589-600.
Chen, L. et al., “Effect of Blood Perfusion on the ablation of liver perenchyma with high intensity focused ultrasound,” Phys. Med. Biol; 38:1661-1673; 1993b.
Damianou et al., Application of the Thermal Dose Concept for Predicting the Necrosed Tissue Volume During Ultrasound Surgery, 1993 IEEE Ultrasound Symposium, pp. 1199-1202.
Fry, W.J. et al., “Production of Focal Destructive Lesions in the Central Nervous System with Ultrasound,” J. Neurosurg., 11:471-478; 1954.
Harr, G.R. et al., “Tissue Destruction with Focused Ultrasound in Vivo,” Eur. Urol. 23 (suppl. 1):8-11; 1993.
Jeffers et al., “Evaluation of the Effect of Cavitation Activity on Drug-Ultrasound Synergisms,” 1993 IEEE Ultrasonics Symposium, pp. 925-928.
Madersbacher, S. et al., “Tissue Ablation in Bening Prostatic Hyperplasia with High Intensity Focused Ultrasound,” Dur. Urol., 23 (suppl. 1):39-43; 1993.
Saad et al., “Ultrasound-Enhanced Effects of Adriamycin Against Murine Tumors,” Ultrasound in Med. & Biol. vol. 18, No. 8, pp. 715-723 (1992).
Simon et al., “Applications of Lipid-Coated Microbubble Ultrasonic Contrast to Tumor Therapy,” Ultrasound in Med. & Biol. vol. 19, No. 2, pp. 123-125 (1993).
Talbert, D. G., “An Add-On Modification for Linear Array Real-Time Ultrasound Scanners to Produce 3D Displays,” UTS Int'l 1977 Brighton, England (Jun. 28-30, 1977) pp. 57-67.
Tata et al., “Interaction of Ultrasound and Model Membrane Systems: Analyses and Predictions,” American Chemical Society, Phys. Chem. 1992, 96, pp. 3548-3555.
Alster, Tinas S., Tanzi, Elizabeth L., “Cellulite Treatment using a Novel Combination Radiofrequency, Infrared Light, and Mechanical Tissue Manipulation Device,” Journal of Cosmetic & Laser Therapy, Jun. 2005, vol. 7, Issue 2, pp. 81-85.
Barthe et al., “Ultrasound therapy system and abiation results utilizing miniature imaging/therapy arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1792-1795, vol. 3.
Coon, Joshua et al., “Protein identification using sequential ion/ion reactions and tandem mass spectometry” Proceedings of the National Academy of Sciences of the USA, vol. 102, No. 27, Jul. 5, 2005, pp. 9463-9468.
Corry, Peter M., et al., “Human Cancer Treatment with Ultrasound”, IEEE Transactions on Sonics and Ultrasonics, vol. SU-31, No. 5, Sep. 1984, pp. 444,456.
Daum et al., “Design and Evaluation of a Feedback Based Phased Array System for Ultrasound Surgery,” IEEE Transactions on Ultrasonics, Feroelectronics, and Frequency Control, vol. 45, No. 2, Mar. 1998, pp. 431-438.
Davis, Brian J., et al., “An Acoustic Phase Shift Technique for the Non-Invasive Measurement of Temperature Changes in Tissues”, 1985 Ultrasonics Symposium, pp. 921-924.
Gliklich et al., Clinical Pilot Study of Intense Ultrasound therapy to Deep Dermal Facial Skin and Subcutaneous Tissues, Arch Facial Plastic Surgery, Mar. 1, 2007, vol. 9.
Hassan et al., “Structure and Applications of Poly(vinyl alcohol) Hydrogels Produced by Conventional Crosslinking or by Freezing/Thawing Methods,” advanced in Polymer Science, 2000, pp. 37-65, vol. 153.
Hassan et al., “Structure and Morphology of Freeze/Thawed PVA Hydrogels,” Macromolecules, Mar. 11, 2000, pp. 2472-2479, vol. 33, No. 7.
Husseini et al, “The Role of Cavitation in Acoustically Activated Drug Delivery,” J. Control Release, Oct. 3, 2005, pp. 253-261, vol. 107(2).
Husseini et al. “Investigating the mechanism of accoustically activated uptake of drugs from Pluronic micelles,” BMD Cancer 2002, 2:20k, Aug. 30, 2002, pp. 1-6.
Jenne, J., et al., “Temperature Mapping for High Energy US-Therapy”, 1994 Ultrasonics Symposium, pp. 1879-1882.
Johnson, S.A., et al., “Non-Intrusive Measurement of Microwave and Ultrasound-Induced Hyperthermia by Acoustic temperature Tomography”, Ultrasonics Symposium Proceedings, pp. 977-982.
Makin et al, “B-Scan Imaging and Thermal Lesion Monitoring Using Miniaturized Dual-Functionality Ultrasound Arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1788-1791, vol. 3.
Makin et al, “Miniaturized Ultrasound Arrays for Interstitial Ablation and Imaging,” UltraSound Med. Biol. 2005, Nov. 1, 2005, pp. 1539-1550, vol. 31(11).
Makin et al., “Confirmal Bulk Ablation and Therapy Monitoring Using Intracorporeal Image-Treat Ultrasound Arrays”, 4th International Symposium on Therapeutic Ultrasound, Sep. 19, 2004.
Manohar et al, “Photoaccoustic mammography laboratory prototype: imaging of breast tissue phantoms,” Journal of Biomedical Optics, Nov./Dec. 2004, pp. 1172-1181, vol. 9, No. 6.
Mast et al, “Bulk Ablation of Soft Tissue with Intense Ultrasound; Modeling nad Experiments,” J. Acoust. Soc. Am., Oct. 1, 2005, pp. 2715-2724, vol. 118(4).
Paradossi et al., “Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications,” Journal of Materials Science: Materials in Medicine, 2003, pp. 687-691, vol. 14.
Reid, Gavin, et al., “Tandem Mass spectrometry of ribonuclease A and B: N-linked glycosylation site analysis of whole protein ions,” Analytical Chemistry. Feb. 1, 2002, vol. 74, No. 3, pp. 577-583.
Righetti et al, “Elastographic Characterization of HIFU-Induced Lesions in Canine Livers,” 1999, Ultrasound in Med & Bio, vol. 25, No. 7, pp. 1099-1113.
Mitragotri, Samir; “Healing sound: the use of ultrasound in drug delivery and other therapeutic applications,” Nature Reviews; Drug Delivery, pp. 255-260, vol. 4.
Sanghvi, N. T., et al., “Transrectal Ablation of Prostrate Tissue Using Focused Ultrasound,” 1993 Ultrasonics Symposium, IEEE, pp. 1207-1210.
Seip, Ralf, et al., “Noninvasive Detection of Thermal Effects Due to Highly Focused Ultrasonic Fiels,” IEEE Symposium, pp. 1229-1232, vol. 2, Oct. 3-Nov. 1993.
Seip, Ralf, et al., “Noninvasive Estimation of Tissue Temperature Response to Heating Fields Using Diagnostic Ultrasound,” IEEE Transactions on Biomedical Engineering, vol. 42, No. 8, Aug. 1995, pp. 828-839.
Smith, Nadine Barrie, et al., “Non-Invasive in Vivo Temperature Mapping of Ultrasound Heating Using Magnetic Resonance Techniques”, 1994 Ultrasonics Symposium, pp. 1829-1832, vol. 3.
Surry et al., “Poly(vinyl alcohol) cryogel phantoms for use in ultrasound and MR imaging,” Phys. Med. Biol., Dec. 6, 2004, pp. 5529-5546, vol. 49.
Syka J. E. P. et al., “Peptide and Protein Sequence Analysis by Electron Transfer Dissociation Mass Spectometry,” Proceedings of the National Academy of Sciences of USA, National Academy of Aceince, Washington, DC, vol. 101, No. 26, Jun. 29, 2004, pp. 9528-9533.
Ueno, S., et al., “Ultrasound Thermometry in Hyperthermia”, 1990 Ultrasonic Symposium, pp. 1645-1652.
Wang, H., et al., “Limits on Focused Ultrasound for Deep Hyperthermia”, 1994 Ultrasonic Symposium, Nov. 1-4, 1994, pp. 1869-1872, vol. 3.
White et al “Selective Creation of Thermal Injury Zones in the Superficial Musculoaponeurotic System Using Intense Ultrasound Therapy,” Arch Facial Plastic Surgery, Jan./Feb. 2007, vol. 9, No. 1.
Sassen, Sander, “ATI's R520 architecture, the new king of the hill?” http://www.hardwareanalysis.com/content/article/1813, Sep. 16, 2005, 2 pages.
Wasson, Scott, “NVIDIA's GeFroce 7800 GTX graphics processor Power MADD,” http://techreport.com/reviews/2005q2/geforce-7800gtx/index.x?pg=1, Jun. 22, 2005, 4 pages.
European Examination Report in related Application No. 05808908.7 dated Jun. 29, 2009.
European Examination Report in related Application No. 05810308.6 dated Jun. 29, 2009.
European Examination Report in related Application No. 10185100.4 dated Jan. 6, 2014.
European Examination Report in related Application No. 10185120.2 dated Jan. 22, 2014.
Decision of the Korean Intellectual Property Tribunal dated Jun. 28, 2013 regarding Korean Patent No. 10-1142108, which is related to the pending application and/or an application identified in the Table on the pp. 2-5 of the information Disclosure Statement herein (English translation, English translation certification, and Korean decision included).
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046122.
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046123.
International Search Report and Written Opinion dated Jan. 28, 2012 in Application No. PCT/US2012/046327.
International Search Report and Written Opinion dated Jan. 28, 2013 in Application No. PCT/US2012/046125.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001361.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001362.
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001366.
International Search Report and Written Opinion dated Apr. 6, 2012 in Application No. PCT/US2011/001367.
Calderhead, et al., One Mechanism Behind LED Photo-Therapy for Wound Healing and Skin Rejuvenation: Key Role of the Mast Cell, Laser Therapy, 2008, 17.3:141-148.
PCT International Preliminary Report on Patentability, PCT/US2011/001366, Feb. 14, 2013, 6 pages.
European Patent Office, Extended Search Report, EP 09835856.7, Apr. 11, 2014, 6 pages.
PCT International Search Report and Written Opinion, PCT/US2014/030779, Sep. 1, 2014, 8 pages.
European Patent Office, Examination Report, EP 07814933.3, Aug. 5, 2014, 5 pages.
European Patent Office, Examination Report, EP 05798870.1, Oct. 20, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185100.4, Oct. 24, 2014, 4 pages.
European Patent Office, Examination Report, EP 10185112.9, Oct. 24, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185117.8, Oct. 24, 2014, 5 pages.
European Patent Office, Examination Report, EP 10185120.2, Oct. 24, 2014, 4 pages.
Related Publications (1)
Number Date Country
20130018286 A1 Jan 2013 US
Provisional Applications (2)
Number Date Country
61506609 Jul 2011 US
61506610 Jul 2011 US